Company intelligence / Profile preview

DETECHBio

Ownership: Private
Development stage: Other

Overview

DETECHBio is a biotechnology company focused on developing advanced biosensing technologies for rapid and accurate detection of biological analytes. The company's core technology leverages innovative molecular recognition elements and signal transduction mechanisms to create portable, high-sensitivity diagnostic tools. Their primary applications include the detection of infectious pathogens, cancer biomarkers, and environmental contaminants. DETECHBio aims to bridge the gap between laboratory-grade testing and point-of-care accessibility through its proprietary platform.

Therapeutic areas: OncologyOtherInfectious Diseases
Modalities: DiagnosticBiosensor
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on DETECHBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DETECHBio.

Explore the full profile